Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Total Current Liabilities (2022 - 2026)

HeartSciences' Total Current Liabilities history spans 5 years, with the latest figure at $4.3 million for Q1 2026.

  • For Q1 2026, Total Current Liabilities rose 19.53% year-over-year to $4.3 million; the TTM value through Jan 2026 reached $4.3 million, up 19.53%, while the annual FY2025 figure was $3.7 million, 111.4% up from the prior year.
  • Total Current Liabilities reached $4.3 million in Q1 2026 per HSCS's latest filing, up from $1.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $4.3 million in Q1 2026 to a low of $1.4 million in Q3 2024.
  • Average Total Current Liabilities over 5 years is $2.6 million, with a median of $2.5 million recorded in 2023.
  • The largest YoY upside for Total Current Liabilities was 123.02% in 2025 against a maximum downside of 52.57% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $3.1 million in 2022, then grew by 12.5% to $3.5 million in 2023, then decreased by 6.47% to $3.3 million in 2024, then plummeted by 52.57% to $1.6 million in 2025, then soared by 172.53% to $4.3 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Total Current Liabilities are $4.3 million (Q1 2026), $1.6 million (Q4 2025), and $3.0 million (Q3 2025).